terican

Last verified · v1.0

Calculator · health

Revised Geneva Score For Pulmonary Embolism Calculator

Calculate pulmonary embolism pre-test probability with the Revised Geneva Score — a validated, fully objective 8-variable clinical decision tool.

FreeInstantNo signupOpen source

Inputs

Revised Geneva Score

—

Explain my result

0/3 free

Get a plain-English breakdown of your result with practical next steps.

Revised Geneva Score—points

The formula

How the
result is
computed.

What Is the Revised Geneva Score?

The Revised Geneva Score is a validated clinical decision tool used to stratify a patient's pre-test probability of pulmonary embolism (PE) in emergency and inpatient settings. Originally developed by Le Gal et al. in 2006, the score relies on eight fully objective clinical variables — eliminating the subjective clinician-judgment component present in earlier models such as the original Geneva Score. This objectivity makes the tool reproducible across different providers, specialties, and institutions worldwide.

Scoring Formula

The total Revised Geneva Score equals the sum of weighted points assigned to each positive clinical finding. Each variable carries a fixed integer weight ranging from 1 to 5:

  • Age > 65 years: +1 point
  • Previous DVT or PE: +3 points
  • Surgery or lower-limb fracture within 1 month: +2 points
  • Active malignant condition: +2 points
  • Unilateral lower-limb pain: +3 points
  • Hemoptysis: +2 points
  • Heart rate 75–94 bpm: +3 points
  • Heart rate ≥ 95 bpm: +5 points
  • Pain on deep venous palpation AND unilateral edema: +4 points

The maximum possible score is 22 points. Each variable is binary except heart rate, which uses two thresholds to capture graduated hemodynamic compromise.

Risk Stratification

Three-Tier Classification

  • Low probability (0–3 points): PE prevalence approximately 8%. A negative high-sensitivity D-dimer test effectively rules out PE without CT imaging.
  • Intermediate probability (4–10 points): PE prevalence approximately 29%. CT pulmonary angiography (CTPA) is recommended.
  • High probability (≥ 11 points): PE prevalence approximately 74%. Immediate CTPA or empiric anticoagulation is warranted.

Two-Tier (Dichotomized) Classification

A validated binary version simplifies decision-making at the bedside:

  • PE unlikely (0–5 points): Obtain D-dimer testing; image only if positive.
  • PE likely (≥ 6 points): Proceed directly to CTPA regardless of D-dimer result.

Variable Definitions and Clinical Rationale

Age Over 65 Years (+1)

Advanced age is an independent VTE risk factor. Reduced mobility, accumulating comorbidities, and diminished fibrinolytic capacity contribute to a prothrombotic state in older adults.

Previous DVT or PE (+3)

A prior thromboembolic event is among the strongest predictors of recurrence, reflecting persistent hypercoagulable states or insufficient treatment duration in previous episodes.

Surgery or Fracture Within 1 Month (+2)

General anesthesia and lower-limb fractures trigger venous stasis, endothelial injury, and coagulation cascade activation — the three pillars of Virchow's triad — sharply elevating thrombosis risk in the perioperative period.

Active Malignancy (+2)

Cancer increases VTE risk 4- to 7-fold through tumor-derived procoagulants and systemic inflammation. The criterion includes solid and hematologic malignancies, as well as those considered cured within the past 12 months.

Unilateral Lower-Limb Pain (+3)

Asymmetric leg pain suggests proximal DVT, the most common embolic source. Its presence substantially raises the pre-test PE probability in acutely ill patients.

Hemoptysis (+2)

Blood-streaked or frank sputum indicates pulmonary infarction distal to an occluded artery — a high-specificity symptom that directly implicates embolic disease as the underlying etiology.

Heart Rate (+3 or +5)

Tachycardia reflects hemodynamic strain caused by obstructed pulmonary circulation. A resting heart rate of 75–94 bpm scores +3 points; a rate ≥ 95 bpm scores +5 points, signaling escalating right ventricular compromise.

DVT Signs: Palpation Pain and Unilateral Edema (+4)

Physical examination findings of a tender, swollen limb consistent with DVT carry the second-highest individual point value, directly supporting a thromboembolic source and strengthening the clinical case for PE.

Worked Clinical Example

A 71-year-old patient presents to the emergency department with right-leg swelling, a resting heart rate of 102 bpm, and a history of colon cancer treated 9 months ago. Scoring: Age > 65 (+1) + Active malignancy (+2) + HR ≥ 95 bpm (+5) + Unilateral edema with deep palpation pain (+4) = 12 points — High Probability. Immediate CTPA is indicated without waiting for D-dimer results.

Validation and Evidence Base

The Revised Geneva Score was prospectively validated in a multicenter cohort of 1,092 patients across Switzerland and France, achieving an area under the ROC curve (AUC) of 0.74. Research published via the National Institutes of Health (PMC) confirms the score performs comparably to Wells' criteria while offering complete provider-independent objectivity. Its integration with age-adjusted D-dimer thresholds — detailed at Boston University Medical Campus — is endorsed in diagnostic algorithms by the European Society of Cardiology (ESC) and the American College of Chest Physicians (ACCP), establishing the Revised Geneva Score as a cornerstone of modern PE workup protocols.

Reference

Frequently asked questions

What is the Revised Geneva Score for pulmonary embolism?
The Revised Geneva Score is a validated, fully objective clinical scoring system that estimates a patient's pre-test probability of pulmonary embolism using eight measurable variables: age over 65, prior DVT or PE, recent surgery or fracture, active malignancy, unilateral leg pain, hemoptysis, resting heart rate, and DVT signs on examination. Total scores stratify patients into low (0–3), intermediate (4–10), or high probability (≥11) categories to guide imaging and anticoagulation decisions.
How do you calculate the Revised Geneva Score step by step?
Assign points for each positive finding: age over 65 (+1), prior DVT or PE (+3), surgery under general anesthesia or lower-limb fracture in the past month (+2), active malignancy (+2), unilateral lower-limb pain (+3), hemoptysis (+2), heart rate 75–94 bpm (+3) or heart rate 95 bpm and above (+5), and deep venous palpation pain with unilateral edema (+4). Sum all applicable points. A total of 0–3 indicates low probability, 4–10 intermediate, and 11 or more high probability of pulmonary embolism.
What score indicates high probability of pulmonary embolism on the Revised Geneva Score?
A Revised Geneva Score of 11 or more points places a patient in the high-probability category, which corresponds to a pulmonary embolism prevalence of approximately 74% in prospectively validated cohorts. At this threshold, clinical guidelines from the European Society of Cardiology recommend immediate CT pulmonary angiography or empiric anticoagulation therapy without awaiting D-dimer results, given the very high pre-test likelihood of confirmed PE.
How does the Revised Geneva Score differ from the Wells PE score?
The fundamental distinction is objectivity. The Wells PE score includes a subjective criterion — clinician judgment that PE is the most likely diagnosis — which introduces measurable inter-observer variability between providers. The Revised Geneva Score uses only quantifiable, bedside-measurable clinical findings, making it fully reproducible. Both scores achieve comparable diagnostic accuracy with an AUC of approximately 0.74, but the Revised Geneva Score is preferred in multicenter research settings and when standardized application across different providers is essential.
Can a low Revised Geneva Score rule out pulmonary embolism without CT imaging?
A low-probability score of 0–3 points, combined with a negative high-sensitivity D-dimer test (below 500 ng/mL, or an age-adjusted threshold of age x 10 ng/mL in patients over 50), effectively excludes PE without CT pulmonary angiography in the majority of clinical guideline recommendations. This strategy avoids unnecessary radiation exposure and iodinated contrast in a significant proportion of emergency department patients. However, individual clinical judgment always governs final management, and physicians may still order imaging based on atypical presentations or patient-specific factors.
Who should use the Revised Geneva Score calculator?
The Revised Geneva Score calculator is designed for licensed healthcare professionals — physicians, nurse practitioners, and physician assistants — evaluating adult patients who present with signs or symptoms suspicious for pulmonary embolism in emergency, urgent care, or inpatient settings. It supports, but does not replace, comprehensive clinical assessment including full history, physical examination, and locally available laboratory and imaging resources. The tool is not validated for pediatric populations and is not intended for patient self-diagnosis.